Sudbury, MA, United States of America

Eric Zanelli

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eric Zanelli

Introduction

Eric Zanelli is a notable inventor based in Sudbury, MA (US), recognized for his significant contributions to the field of vaccine development. With a total of five patents to his name, Zanelli has made strides in creating innovative methods for designing and preparing vaccines.

Latest Patents

One of his latest patents is titled "Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes." This invention outlines a process for preparing a composition that includes directed sequence polymer (DSP) mixtures, which serve as epitopes useful for vaccines. The DSP is synthesized based on specific rules regarding the identity and frequency of amino acids that replace a base or native amino acid of a known epitope. The resulting composition consists of a mixture of related peptides intended for therapeutic use as a vaccine, particularly against immune evasive infectious agents.

Another significant patent is "Serum protein-based detection of random sequence polymer compositions." This application addresses the challenges in detecting simple peptides and provides improved methods for detecting and assessing random sequence polymer (RSP) compositions. It includes methods for quantifying RSP compositions and determining a subset of peptides based on their interactions with specific capture polypeptides. Additionally, it outlines methods for administering RSP compositions to subjects, allowing for tailored dosage regimens based on detection and quantitation methods.

Career Highlights

Throughout his career, Eric Zanelli has worked with various companies, including Ares Trading S.a. and Peptimmune, Inc. His experience in these organizations has contributed to his expertise in the field of peptide-based therapeutics and vaccine development.

Collaborations

Zanelli has collaborated with notable individuals in his field, including Dustan Bonnin and James Rasmussen. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in vaccine technology.

Conclusion

Eric Zanelli's work exemplifies the impact of innovation in vaccine development. His patents and career achievements highlight his commitment to advancing medical science through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…